High doses of vitamin D3 may decrease bone loss associated with anti-HIV drug
A monthly high dose of vitamin D3 may prevent the loss of bone density often experienced by people taking the anti-HIV drug tenofovir disoproxil fumarate (TDF).
NICHD issues Releases and Media Advisories to the news media. Science Updates and Spotlights explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement such as an initiative launch or a notable staff change. Director’s Corner posts are monthly updates from the NICHD director.